Prestige Consumer Healthcare Inc.
General ticker "PBH" information:
- Sector: Health Care
- Industry: Medical - Distribution
- Capitalization: $3.4B (TTM average)
Prestige Consumer Healthcare Inc. does not follow the US Stock Market performance with the rate: -30.6%.
Estimated limits based on current volatility of 2.2%: low 54.98$, high 57.43$
Factors to consider:
- Earnings expected soon, date: 2026-05-14 bmo
- Total employees count: 570 (+1.8%) as of 2024
- US accounted for 78.8% of revenue in the fiscal year ended 2024-03-31
- Top business risk factors: Third-party risks, Market competition, Cybersecurity threats, Geopolitical risks, Product development risks
- Current price 14.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [65.53$, 88.85$]
- 2026-03-31 to 2027-03-31 estimated range: [64.70$, 88.80$]
Financial Metrics affecting the PBH estimates:
- Negative: with PPE of 18.7 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 29.60 > 18.52
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 5.93
- Positive: 42.60 < Shareholder equity ratio, % of 53.93 <= 64.25
- Positive: Investing cash flow per share per price, % of -0.41 > -0.65
- Positive: 0.07 < Operating cash flow per share per price, % of 5.96
- Positive: Industry earnings per price (median), % of 4.60 > 4.54
- Positive: Interest expense per share per price, % of 1.13 <= 3.29
Short-term PBH quotes
Long-term PBH plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | $1,127.72MM | $1,125.36MM | $1,137.76MM |
| Operating Expenses | $1,150.14MM | $782.93MM | $800.99MM |
| Operating Income | $-22.41MM | $342.43MM | $336.77MM |
| Non-Operating Income | $-71.50MM | $-66.40MM | $-52.59MM |
| Interest Expense | $69.16MM | $67.16MM | $47.63MM |
| Income(Loss) | $-93.92MM | $276.02MM | $284.19MM |
| Taxes | $-11.61MM | $66.69MM | $69.58MM |
| Profit(Loss)* | $-82.31MM | $209.34MM | $214.60MM |
| Stockholders Equity | $1,447.08MM | $1,655.08MM | $1,834.90MM |
| Inventory | $162.12MM | $138.72MM | $147.71MM |
| Assets | $3,353.73MM | $3,318.42MM | $3,402.22MM |
| Operating Cash Flow | $229.72MM | $248.93MM | $251.51MM |
| Capital expenditure | $7.78MM | $9.55MM | $8.22MM |
| Investing Cash Flow | $-11.58MM | $-20.11MM | $-17.45MM |
| Financing Cash Flow | $-185.85MM | $-241.01MM | $-182.07MM |
| Earnings Per Share** | $-1.65 | $4.21 | $4.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.